GAD1 and Alzheimer disease: This discrepancy may be because, in this earlier study, GABAergic inhibition was reduced by crossing Gad67 haploinsufficient mice with 5xFAD mice, generating an AD model with a congenital GABAergic defect that might cause alterations not commonly occurring in AD mice.